Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Biomedicines|May 25, 2017
Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy StrategiesDonald Bastin, Scott R Walsh, Meena Al Saigh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 6, 2025
Pre-Encoded IFN-I Sensitivity Exacerbates Memory T Cell Senescence in Solid TumorsAndrew Nguyen, Scott R Walsh, Li Deng, et al.
Cancers|November 13, 2021
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast CancerAlyssa Vito, Nader El-Sayes, Omar Salem, et al.
Micromachines|January 27, 2021
A Transit Time-Resolved Microflow Cytometry-Based Agglutination Immunoassay for On-Site C-Reactive Protein DetectionJianxi Qu, Yushan Zhang, Mathieu Chenier, et al.
Cancer Research|February 20, 2004
Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skinCecilia Lane, Jaina Leitch, Xiaohua Tan, et al.
The Journal of Clinical Investigation|August 16, 2022
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunityAndrew Nguyen, Louisa Ho, Richard Hogg, et al.
Nanoscale Advances|May 2, 2024
The effect of comb length on the <i>in vitro</i> and <i>in vivo</i> properties of self-assembled poly(oligoethylene glycol methacrylate)-based block copolymer nanoparticlesAndrew Singh, Andrew Lofts, Ramya Krishnan, et al.
International Journal of Molecular Sciences|February 15, 2022
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent MannerNader El-Sayes, Alyssa Vito, Omar Salem, et al.
Molecular Therapy Oncolytics|April 11, 2022
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activityNader El-Sayes, Scott Walsh, Alyssa Vito, et al.
European Journal of Immunology|April 2, 2009
CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axisSheng Zhang, Dannie Bernard, Waliul I Khan, et al.
Pageof 9